Selective serotonin reuptake inhibitor use is associated with worse sleep-related breathing disturbances in individuals with depressive disorders and sleep complaints: a retrospective study
Author(s) -
Rébecca Robillard,
Mysa Saad,
L. Bryan Ray,
Brad Bujaki,
Alan B. Douglass,
Elliott K. Lee,
Louis Soucy,
Naomi Spitale,
Joseph De Koninck,
Tetyana Kendzerska
Publication year - 2020
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.8942
Subject(s) - non rapid eye movement sleep , serotonin reuptake inhibitor , polysomnography , medicine , anesthesia , antidepressant , reuptake inhibitor , major depressive disorder , sleep disorder , psychology , psychiatry , insomnia , apnea , electroencephalography , amygdala , hippocampus
The effects of serotonergic agents on respiration neuromodulation may vary according to differences in the serotonin system, such as those linked to depression. This study investigated how sleep-related respiratory disturbances relate to depression and the use of medications commonly prescribed for depression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom